Analysts and investors alike will be keeping a close eye on the performance of Hercules Capital in its upcoming earnings disclosure. In that report, analysts expect Hercules Capital to post earnings of $0.51 per share. This would mark a year-over-year decline of 3.77%. Meanwhile, our latest consensus estimate is calling for revenue of $124.99 million, up 7.53% from the prior-year quarter. Our research shows that these estimate changes are directly correlated with near-term stock prices. To capitalize on thi ...

The yield is big, but as always, there are trade-offs to consider before diving in. Like dividends? A little outfit called Hercules Capital (HTGC -1.31%) dishes them out in a big way. Shares of this business development company boast a trailing dividend yield of a little over 8%, in fact, and that's based on just its ordinary quarterly payout. Adding its supplemental dividend to the mix cranks the trailing-12-month yield up to nearly 10%. Not bad. Before plowing into a new stake in this name based on nothin ...

Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system. Hercules Capital (HTGC) closed the most recent trading day at $19.60, moving -1.31% from the previous trading session. This move lagged the S&P 500's daily gain of 0.23%. Meanwhile, the Dow experienced a drop of 0.17%, and the ...

Shares of the specialty finance company witnessed a loss of 0.45% over the previous month, trailing the performance of the Finance sector with its gain of 1.22% and the S&P 500's gain of 3.51%. Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $2.06 per share and revenue of $503.7 million, indicating changes of -0.96% and +9.34%, respectively, compared to the previous year. Our research reveals that these estimate alterations are directly linked with the stock price performance i ...

$125 million of non-dilutive capital extends projected cash runway into late 2025, excluding expected commercial sales from XOLREMDI™ (mavorixafor) XOLREMDI, the first drug indicated in patients with WHIM syndrome, received U.S. FDA approval in April 2024 BOSTON, May 09, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (NASDAQ:XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that it has completed the sale of its Rare Pediatric Disease Priority Review ...

Meet the high-yield dividend payers that could raise your passive income stream.Investors eager to bulk up their passive income streams can do so without breaking the bank.At recent prices, Hercules Capital (HTGC 1.29%), Altria Group (MO -0.23%), and AT&T (T 0.83%) offer an average yield of 8.5% at recent prices. That's high enough to turn an initial investment of $5,890 into $500 of annual dividend income.There are plenty of dividend stocks with even higher yields right now. These three stand out because t ...

Klaus Vedfelt Hercules Capital, Inc. (NYSE:HTGC) reported robust quarterly earnings for its 1Q last week. The business development company once again covered its dividend with net investment income and achieved another quarter of record total gross fundings. The BDC's income trajectory looks solid, with Hercules Capital seeing 16% YoY total investment income growth, and the company maintained a very strong credit profile. Though Hercules Capital is richly valued, based on net asset value, I continue to see ...

bridgebio SeatGeek CLARABRIDGE Sustainable & Renewable Technology | --- | --- | --- | --- | |--------------------------------|-----------------------------------------|---------------------------------|-------------------------------------------| | | | | | | | | | | | | | | | | | INDUSTRY | | | | FINANCIAL SPONSORS | SECTORS | STAGES OF DEVELOPMENT | GEOGRAPHIC LOCATION | | More than 1000 Venture Capital | Technology SaaS Financing Life Sciences | Expansion or "Venture Growth" & | Key VC Investment Centers ...

Hercules Capital, Inc. (NYSE:HTGC) Q1 2024 Earnings Conference Call May 2, 2024 5:00 PM ET Company Participants Michael Hara - Director of IR Scott Bluestein - CEO & CIO Seth Meyer - CFO Conference Call Participants Crispin Love - Piper Sandler Brian McKenna - Citizen JMP Finian O'Shea - Wells Fargo Casey Alexander - Compass Point John Hecht - Jefferies Vilas Abraham - UBS Christopher Nolan - Ladenburg Thalmann Operator Good day, and thank you for standing by. Welcome to the Hercules Capital First Quarter 2 ...

Exhibit 99.1 Hercules Capital Reports First Quarter 2024 Financial Results Record Q1 2024 Total Gross Debt and Equity Commitments of $956.0 Million, an Increase of 81.7% Year-over-Year Record Q1 2024 Total Gross Fundings of $605.2 Million, an Increase of 27.1% Year-over-Year Q1 2024 Total Investment Income of $121.6 Million, an Increase of 15.7% Year-over-Year Q1 2024 Net Investment Income “NII” of $79.2 Million, or $0.50 per Share, an Increase of 20.9% Year-over-Year Q1 2024 NII Provides 125% Coverage of t ...